ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Kansas » Pulmonary Disease

Top Pulmonary Disease Prescribers in Kansas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ROBERT SOURK MD

Pulmonary Disease

13,814

$905K

658
537 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 58%

$66
Average prescription price

Avg: $183

STEVEN RONSICK MD

Pulmonary Disease

3,300

$1.01M

557
441 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 58%

$307
Average prescription price

Avg: $183

STEVEN SHORT DO

Pulmonary Disease

3,293

$468K

345
291 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 58%

$142
Average prescription price

Avg: $183

LIDA OSBERN M.D.

Pulmonary Disease

3,255

$301K

407
319 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 58%

$92
Average prescription price

Avg: $183

NADER ELDIKA M.D.

Pulmonary Disease

2,615

$599K

369
269 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

76%
prescriptions for brand name drugs

Avg: 58%

$229
Average prescription price

Avg: $183

MARK WENCEL MD

Pulmonary Disease

2,587

$846K

318
261 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 58%

$327
Average prescription price

Avg: $183

STEPHEN HAGAN M.D.

Pulmonary Disease

2,583

$814K

331
233 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

49%
prescriptions for brand name drugs

Avg: 58%

$315
Average prescription price

Avg: $183

WILLIAM LEEDS DO

Pulmonary Disease

2,310

$528K

340
248 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 58%

$229
Average prescription price

Avg: $183

KENT BERQUIST M.D.

Pulmonary Disease

2,252

$374K

354
306 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 58%

$166
Average prescription price

Avg: $183

W. TROMBOLD MD

Pulmonary Disease

1,893

$952K

271
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 58%

$503
Average prescription price

Avg: $183

RICHARD CLAIBORNE MD

Pulmonary Disease

1,693

$262K

227
181 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 58%

$155
Average prescription price

Avg: $183

DOUGLAS LIVINGSTON D.O.

Pulmonary Disease

1,669

$413K

233
188 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 58%

$247
Average prescription price

Avg: $183

SON TRUONG MD

Pulmonary Disease

1,639

$264K

289
233 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 58%

$161
Average prescription price

Avg: $183

JOHN FLESHER MD

Pulmonary Disease

1,531

$500K

245
187 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

71%
prescriptions for brand name drugs

Avg: 58%

$327
Average prescription price

Avg: $183

JAMES KAPLAN M.D.

Pulmonary Disease

1,488

$309K

135
109 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 58%

$207
Average prescription price

Avg: $183

JOSEPH HENRY M.D.

Pulmonary Disease

1,296

$133K

188
148 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 58%

$102
Average prescription price

Avg: $183

SHAWN MAGEE M.D.

Pulmonary Disease

1,292

$203K

166
123 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 58%

$157
Average prescription price

Avg: $183

JASON FIESER MD

Pulmonary Disease

1,264

$255K

257
191 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 58%

$202
Average prescription price

Avg: $183

ALEXIS MEREDITH M.D.

Pulmonary Disease

1,164

$194K

197
157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

62%
prescriptions for brand name drugs

Avg: 58%

$167
Average prescription price

Avg: $183

VLAD DIMITRIU MD

Pulmonary Disease

1,081

$286K

157
117 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 58%

$264
Average prescription price

Avg: $183

AVINASH SINGH MD

Pulmonary Disease

1,034

$182K

168
133 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

61%
prescriptions for brand name drugs

Avg: 58%

$176
Average prescription price

Avg: $183

OSMAN MALIK MD

Pulmonary Disease

995

$286K

131
93 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

70%
prescriptions for brand name drugs

Avg: 58%

$288
Average prescription price

Avg: $183

JOHN NELSON M.D.

Pulmonary Disease

961

$144K

150
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 58%

$150
Average prescription price

Avg: $183

VICTOR SALLOUM MD

Pulmonary Disease

961

$173K

161
103 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

65%
prescriptions for brand name drugs

Avg: 58%

$180
Average prescription price

Avg: $183

MICHAEL NELSON M.D.

Pulmonary Disease

803

$125K

132
116 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

74%
prescriptions for brand name drugs

Avg: 58%

$156
Average prescription price

Avg: $183

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank